CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
EBV BZLF1 Products
Select your EBV BZLF1 Products including PepMix™ Peptide Pools, MHC-Dextramer, Antigen Peptide or Replitope™ Peptide Arrays!
PepMix™ Peptide Pools
PM-EBV-BZLF1
PepMix™ EBV (BZLF1)
Pool of 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4) for T cell assays
Pool of 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4) for T cell assays

PepMix™ EBV (BZLF1)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | BZLF1 Trans-activator protein |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic |
Autoimmune disease Burkitt's lymphoma Hodgkin's lymphoma Nasopharyngeal carcinoma |
Number of peptides | 59 |
Further Information:
Amount | 1 vial containing 15 nmol (appr. 25µg) per peptide |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
NCBI | YP_401673 |
Sequence |
MMDPNSTSEDVKFTPDPYQVPFVQAFDQ ATRVYQDLGGPSQAPLPCVLWPVLPEPL PQGQLTAYHVSTAPTGSWFSAPQPAPEN AYQAYAAPQLFPVSDITQNQQTNQAGGE APQPGDNSTVQTAAAVVFACPGANQGQQ LADIGVPQPAPVAAPARRTRKPQQPESL EECDSELEIKRYKNRVASRKCRAKFKQL LQHYREVAAAKSSENDRLRLLLKQMCPS LDVDSIIPRTPDVLHEDLLNF |
Protein Length (aa) | 245 |

Dextramers®
MHC2148
MHC I Dextramer HLA-B*0801 (RAKFKQLL)
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells

MHC I Dextramer HLA-B*0801 (RAKFKQLL)

Application |
Immune monitoring Immunohistochemistry T-cell assays |
Protein Name | Selected proteins |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic | AIDS (HIV) |
Allele | HLA-B*0801 |
Peptide | RAKFKQLL |
Antigen | BZLF1 |
Category | EBV |
Further Information:
Amount | 1 vial containing 50 /150 / 500 or 1000 tests |
Specifications | Antigen specific MHC class I multimer with dextran backbone |
Documentation | Protocol and Datasheet |
Protein Length (aa) | 0 |

MHC2146
MHC I Dextramer HLA-B*3501 (EPLPQGQLTAY)
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells

MHC I Dextramer HLA-B*3501 (EPLPQGQLTAY)

Application |
Immune monitoring Immunohistochemistry T-cell assays |
Protein Name | Selected proteins |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic | AIDS (HIV) |
Allele | HLA-B*3501 |
Peptide | EPLPQGQLTAY |
Antigen | BZLF1 |
Category | EBV |
Further Information:
Amount | 1 vial containing 50 /150 / 500 or 1000 tests |
Specifications | Antigen specific MHC class I multimer with dextran backbone |
Documentation | Protocol and Datasheet |
Protein Length (aa) | 0 |

MHC3303
MHC I Dextramer HLA-B*3501 (EPLSQSQITAY)
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells
MHC Class I Multimers with dextrane backbone and FITC, APC or PE label. For reproducible detection, enumeration and isolation of antigen-specific T cells

MHC I Dextramer HLA-B*3501 (EPLSQSQITAY)

Application |
Immune monitoring Immunohistochemistry T-cell assays |
Protein Name | Selected proteins |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic | AIDS (HIV) |
Allele | HLA-B*3501 |
Peptide | EPLSQSQITAY |
Antigen | BZLF1 |
Category | EBV |
Further Information:
Amount | 1 vial containing 50 /150 / 500 or 1000 tests |
Specifications | Antigen specific MHC class I multimer with dextran backbone |
Documentation | Protocol and Datasheet |
Protein Length (aa) | 0 |

Antigen Peptides
SP-MHCI-0108
Antigen Peptide EBV BZLF1 HLA-B*0801 (RAKFKQLL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Antigen Peptide EBV BZLF1 HLA-B*0801 (RAKFKQLL)

Sequence | RAKFKQLL |
Category | Infection |
Allele | HLA-B*0801 |
Species | Epstein-Barr virus |
Antigen | EBV BZLF1 |
Uniprot ID | P03206 |
Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | BZLF1 Trans-activator protein |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic |
Autoimmune disease Burkitt's lymphoma Hodgkin's lymphoma Nasopharyngeal carcinoma |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | 8mer peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID | |
Sequence | H-RAKFKQLL-OH |
Protein Length (aa) | 0 |

SP-MHCI-0019
Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Antigen Peptide EBV BZLF1 HLA-B*3501 (EPLPQGQLTAY)

Sequence | EPLPQGQLTAY |
Category | Infection |
Allele | HLA-B*3501 |
Species | Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4) |
Antigen | EBV BZLF1 |
Uniprot ID | P03206 |
Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | BZLF1 Trans-activator protein |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic |
Autoimmune disease Burkitt's lymphoma Hodgkin's lymphoma Nasopharyngeal carcinoma |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | 11mer peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID | |
Sequence | H-EPLPQGQLTAY-OH |
Protein Length (aa) | 0 |

RepliTope™ Peptide Microarrays
RT-MW-EBV-BZLF1
Multiwell RepliTope™ EBV (BZLF1)
Peptide microarray displaying 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4). Incubation with 20 samples (and one control) in parallel using the Array Slide 24-4 chamber
Peptide microarray displaying 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4). Incubation with 20 samples (and one control) in parallel using the Array Slide 24-4 chamber

Multiwell RepliTope™ EBV (BZLF1)

Application |
Antibody epitope discovery Immune monitoring |
Protein Name | BZLF1 Trans-activator protein |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic |
Autoimmune disease Burkitt's lymphoma Hodgkin's lymphoma Nasopharyngeal carcinoma |
Number of peptides | 59 |
Further Information:
Amount | 1 peptide microarray (each peptide is deposited 3x per subarray, 21 subarrays per slide) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol, Datasheet, gal-file and gal-viewer |
Swiss-Prot ID | |
NCBI | YP_401673 |
Sequence |
MMDPNSTSEDVKFTPDPYQVPFVQAFDQ ATRVYQDLGGPSQAPLPCVLWPVLPEPL PQGQLTAYHVSTAPTGSWFSAPQPAPEN AYQAYAAPQLFPVSDITQNQQTNQAGGE APQPGDNSTVQTAAAVVFACPGANQGQQ LADIGVPQPAPVAAPARRTRKPQQPESL EECDSELEIKRYKNRVASRKCRAKFKQL LQHYREVAAAKSSENDRLRLLLKQMCPS LDVDSIIPRTPDVLHEDLLNF |
Protein Length (aa) | 245 |

RT-EBV-BZLF1
RepliTope™ EBV (BZLF1)
Peptide microarray displaying 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4)
Peptide microarray displaying 59 peptides derived from a peptide scan through Trans-activator protein BZLF1 of Epstein-Barr virus (HHV4)

RepliTope™ EBV (BZLF1)

Application |
Antibody epitope discovery Immune monitoring |
Protein Name | BZLF1 Trans-activator protein |
Organism | Epstein-Barr virus (HHV-4) |
Indication / Topic |
Autoimmune disease Burkitt's lymphoma Hodgkin's lymphoma Nasopharyngeal carcinoma |
Number of peptides | 59 |
Further Information:
Amount | 1 peptide microarray (each peptide is deposited 3x per subarray, 4 subarrays per slide) + dummy slide and spacers (needed for manual incubation) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol, Datasheet, gal-file and gal-viewer |
Swiss-Prot ID | |
NCBI | YP_401673 |
Sequence |
MMDPNSTSEDVKFTPDPYQVPFVQAFDQ ATRVYQDLGGPSQAPLPCVLWPVLPEPL PQGQLTAYHVSTAPTGSWFSAPQPAPEN AYQAYAAPQLFPVSDITQNQQTNQAGGE APQPGDNSTVQTAAAVVFACPGANQGQQ LADIGVPQPAPVAAPARRTRKPQQPESL EECDSELEIKRYKNRVASRKCRAKFKQL LQHYREVAAAKSSENDRLRLLLKQMCPS LDVDSIIPRTPDVLHEDLLNF |
Protein Length (aa) | 245 |

News
13 NEW Immunopeptidomics Kits
References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more
Infectious diseases beyond COVID-19
JPT's peptide formats in the literature
(Oct 2020)
Read more
SARS COV-2 Mass Spec Reference Kit Released!:
SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more
New! SARS-CoV-2 Epitope Mapping Peptide Sets
Save time and samples and check our new SARS-CoV-2 Epitope Mapping Peptide Sets (EMPS).
(Apr 2020)
Read more
Quality Assurance
All production is performed according to ISO 9001:2015 standards.